David S. Karow

Biography

  David S. Karow, M.D., Ph.D., Chief Medical Imaging Officer at HLI, is an innovative leader in the medical imaging space who brings more than 10 years of experience in advanced MR Imaging, focused on the development and translation into clinical care of diffusion-based MRI techniques. Dr. Karow is the Chief Radiologist at HLI’s Health Nucleus. Before joining HLI, Dr. Karow was the Director of Body MRI within the Body Imaging Division and Director of Acute Care Imaging in the Department of Radiology at University of California, San Diego (UC San Diego), where he still serves as Associate Professor, Health Sciences Clinical and Associate Director, Center for Translational Imaging and Precision Medicine. During his time at UC San Diego he, in collaboration with Dr. Anders Dale, Ph.D., in the Center for MultiModal Imaging and Genetics (CMIG), implemented a new, advanced diffusion method (RSI) that proved beneficial for the detection and in vivo characterization of prostate tumors. He worked to create a standard MRI protocol that is obtained on patients with proven or suspected prostate cancer. The protocol made it possible to obtain standardized, high quality quantitative imaging, which has greatly enhanced the ability to detect, localize and characterize prostate cancer. The work has yielded multiple published papers and led to multiple federal and private research grants on which Dr. Karow was Principal Investigator. Dr. Karow and collaborators continue to investigate using RSI-MRI as a biomarker for cervical cancer radiotherapy treatment response, and are compiling data showing that these techniques may be useful for the screening and staging of cancer across the whole body including breast cancer.  

Research Interest

  biomarker for cervical cancer radiotherapy